Affinivax Inc.

Affinivax Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Affinivax was acquired by GSK in August 2022. Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.

Company Details

Employees
16
Address
Cambridge, Massachusetts, Us
Phone
617-465-0865
Email
co****@****vax.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge, Massachusetts
Looking for a particular Affinivax Inc. employee's phone or email?

Affinivax Inc. Questions

News

CEPI partners with Affinivax to develop a novel COVID-19 vaccine to target variants - CEPI

CEPI partners with Affinivax to develop a novel COVID-19 vaccine to target variants CEPI

GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc. - GSK

GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc. GSK

GSK axes vaccine from $2.1B deal, switching to preclinical successor over 'increased competition' - Fierce Biotech

GSK axes vaccine from $2.1B deal, switching to preclinical successor over 'increased competition' Fierce Biotech

Affinivax Appoints Vanya Sagar as Chief People Officer - Business Wire

Affinivax Appoints Vanya Sagar as Chief People Officer Business Wire

GSK wagers $2.1B on Affinivax and its next-generation pneumonia vaccine - BioPharma Dive

GSK wagers $2.1B on Affinivax and its next-generation pneumonia vaccine BioPharma Dive

GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster - Reuters

GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster Reuters

GSK expands vaccine portfolio with $3.3-billion deal for Affinivax - FirstWord Pharma

GSK expands vaccine portfolio with $3.3-billion deal for Affinivax FirstWord Pharma

GSK to acquire clinical-stage biopharmaceutical company Affinivax - Labiotech.eu

GSK to acquire clinical-stage biopharmaceutical company Affinivax Labiotech.eu

GSK gets pneumococcal vaccine contender with $2.1B Affinivax acquisition - MedCity News

GSK gets pneumococcal vaccine contender with $2.1B Affinivax acquisition MedCity News

GSK to acquire Affinivax for MAPS vaccine platform - European Pharmaceutical Review

GSK to acquire Affinivax for MAPS vaccine platform European Pharmaceutical Review

GSK Bolsters Vaccines Business with $3.3B Affinivax Buy - BioSpace

GSK Bolsters Vaccines Business with $3.3B Affinivax Buy BioSpace

GSK Bolsters Vaccine Business With $3.3 Billion Deal for Affinivax - WSJ - The Wall Street Journal

GSK Bolsters Vaccine Business With $3.3 Billion Deal for Affinivax - WSJ The Wall Street Journal

GSK takes Affinivax in $3.3B deal, MAPS way in pneumococcal disease - BioWorld MedTech

GSK takes Affinivax in $3.3B deal, MAPS way in pneumococcal disease BioWorld MedTech

Affinivax reacquires rights from Astellas for ASP3772 - The Pharma Letter

Affinivax reacquires rights from Astellas for ASP3772 The Pharma Letter

GSK strikes $3.3B Affinivax buyout to MAP out challenge to Pfizer's blockbuster pneumococcal vaccine - Fierce Biotech

GSK strikes $3.3B Affinivax buyout to MAP out challenge to Pfizer's blockbuster pneumococcal vaccine Fierce Biotech

Affinivax Appoints Elizabeth Radcliffe as Chief Financial Officer - Business Wire

Affinivax Appoints Elizabeth Radcliffe as Chief Financial Officer Business Wire

Affinivax and Astellas take a shot at pneumococcus vaccine - BioPharma Dive

Affinivax and Astellas take a shot at pneumococcus vaccine BioPharma Dive

Affinivax Appoints Stuart Chaffee, PhD, as Chief Business Officer - BioSpace

Affinivax Appoints Stuart Chaffee, PhD, as Chief Business Officer BioSpace

Merck's pediatric Vaxneuvance lead departs to help develop rival vaccine at Affinivax - Fierce Biotech

Merck's pediatric Vaxneuvance lead departs to help develop rival vaccine at Affinivax Fierce Biotech

GSK to buy Cambridge vaccine startup Affinivax for $2.1b, with more payments possible - The Boston Globe

GSK to buy Cambridge vaccine startup Affinivax for $2.1b, with more payments possible The Boston Globe

$120 Million Financing to Advance MAPS Vaccines - Vax-Before-Travel

$120 Million Financing to Advance MAPS Vaccines Vax-Before-Travel

Cambridge vaccine startup raises $120M as Covid-19 spotlights need - The Business Journals

Cambridge vaccine startup raises $120M as Covid-19 spotlights need The Business Journals

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion - Indian Pharma Post

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion Indian Pharma Post

LabCentral to Open Next-Stage Facility for Growing Life Science Companies, Supported by Pfizer - GlobeNewswire

LabCentral to Open Next-Stage Facility for Growing Life Science Companies, Supported by Pfizer GlobeNewswire

CARB-X funds Affinivax millions for Staphylococcus aureus bacterial infection vaccine - Homeland Preparedness News

CARB-X funds Affinivax millions for Staphylococcus aureus bacterial infection vaccine Homeland Preparedness News

GSK strikes deal to buy US vaccine firm Affinivax - Jersey Evening Post

GSK strikes deal to buy US vaccine firm Affinivax Jersey Evening Post

Top Affinivax Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant